Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22
暂无分享,去创建一个
Shelly C. Lu | S. Y. Kim | S. Devkota | Yutong Zhao | E. Seki | D. Carson | Tomoko Hayashi | Y. Roh | Michael Chan | H. Matsushita | K. Ohashi | M. Matsuda | Qinglan Wang | V. Pandyarajan | T. Tsuchiya | Zhijun Wang | C. Kiani | S. Kim
[1] V. Shah,et al. Interleukin-22 in alcoholic hepatitis and beyond , 2020, Hepatology International.
[2] P. Higgins,et al. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota , 2020, Nature Medicine.
[3] V. Shah,et al. Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming of impaired regeneration pathways in mice. , 2019, Journal of hepatology.
[4] Douglas A. Simonetto,et al. An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis , 2019, Hepatology.
[5] Zhou Zhou,et al. Interleukin‐22 Ameliorates Neutrophil‐Driven Nonalcoholic Steatohepatitis Through Multiple Targets , 2019, Hepatology.
[6] L. Capurso. Thirty Years of Lactobacillus rhamnosus GG: A Review. , 2019, Journal of clinical gastroenterology.
[7] O. Fiehn,et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice , 2018, Gut.
[8] J. E. Mejía,et al. Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation , 2018, Seminars in Immunopathology.
[9] K. Tsuneyama,et al. The interplay of type I and type II interferons in murine autoimmune cholangitis as a basis for sex‐biased autoimmunity , 2018, Hepatology.
[10] Xiaoling Li,et al. Interleukin-22 Prevents Microbial Dysbiosis and Promotes Intestinal Barrier Regeneration Following Acute Injury , 2017, Shock.
[11] Xiaomin Su,et al. Gut REG3γ-Associated Lactobacillus Induces Anti-inflammatory Macrophages to Maintain Adipose Tissue Homeostasis , 2017, Front. Immunol..
[12] Yu-Wen Su,et al. Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation , 2017, Journal of immunology research.
[13] B. Schnabl,et al. Bidirectional Communication between Liver and Gut during Alcoholic Liver Disease , 2016, Seminars in Liver Disease.
[14] J. Kwon,et al. Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease , 2016, Scientific Reports.
[15] A. Horvath,et al. Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity. , 2016, American journal of physiology. Gastrointestinal and liver physiology.
[16] C. Buffie,et al. TLR-7 activation enhances IL-22–mediated colonization resistance against vancomycin-resistant enterococcus , 2016, Science Translational Medicine.
[17] D. Brenner,et al. Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation. , 2016, Cell host & microbe.
[18] E. Seki,et al. TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration. , 2015, American journal of physiology. Gastrointestinal and liver physiology.
[19] Shiyin Yao,et al. Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes , 2015, PloS one.
[20] K. Kodys,et al. Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS , 2015, Scientific Reports.
[21] M. V. D. van den Brink,et al. Interleukin-22: immunobiology and pathology. , 2015, Annual review of immunology.
[22] S. Endres,et al. Modes of action of TLR7 agonists in cancer therapy. , 2014, Immunotherapy.
[23] G. Núñez,et al. Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. , 2014, Immunity.
[24] E. Seki,et al. Toll‐like receptor 7‐mediated type I interferon signaling prevents cholestasis‐ and hepatotoxin‐induced liver fibrosis , 2014, Hepatology.
[25] M. Neurath,et al. Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis , 2013, Hepatology.
[26] B. Becher,et al. Langerinneg conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice , 2013, Proceedings of the National Academy of Sciences.
[27] X. Chen,et al. microRNAs are ligands of Toll-like receptors. , 2013, RNA.
[28] B. Gao,et al. Mouse model of chronic and binge ethanol feeding (the NIAAA model) , 2013, Nature Protocols.
[29] B. Gao,et al. Interleukin‐22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice , 2012, Hepatology.
[30] Roberta Galli,et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response , 2012, Proceedings of the National Academy of Sciences.
[31] R. Schwabe,et al. Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis , 2012, Gut.
[32] E. Seki,et al. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut , 2012, The Journal of physiology.
[33] E. Seki,et al. Toll-Like Receptors in Liver Fibrosis: Cellular Crosstalk and Mechanisms , 2012, Front. Physio..
[34] Shiyin Yao,et al. Mast Cell-Mediated Inhibition of Abdominal Neutrophil Inflammation by a PEGylated TLR7 Ligand , 2011, Mediators of inflammation.
[35] R. Bataller,et al. Alcoholic liver disease: pathogenesis and new therapeutic targets. , 2011, Gastroenterology.
[36] J. Renauld,et al. IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice , 2011, The Journal of Immunology.
[37] D. Brenner,et al. Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. , 2011, Alcoholism, clinical and experimental research.
[38] Yanmei Zhang,et al. Synthesis and characterization of PEGylated toll like receptor 7 ligands. , 2011, Bioconjugate chemistry.
[39] A. Dolganiuc,et al. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells , 2011, Hepatology.
[40] R. Bataller,et al. Interleukin‐22 treatment ameliorates alcoholic liver injury in a murine model of chronic‐binge ethanol feeding: Role of signal transducer and activator of transcription 3 , 2010, Hepatology.
[41] B. Gao,et al. Toll-Like Receptor 3 in Liver Diseases , 2010, Gastroenterology research and practice.
[42] M. McGargill,et al. Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7 , 2009, Proceedings of the National Academy of Sciences.
[43] A. Dolganiuc,et al. The critical role of toll‐like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88 , 2008, Hepatology.
[44] J. Casanova,et al. Human Toll‐like receptor‐dependent induction of interferons in protective immunity to viruses , 2007, Immunological reviews.
[45] Yu-Tseung Liu,et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells , 2006, Nature Cell Biology.
[46] R. Sun,et al. Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation , 2004, Hepatology.
[47] S. Akira,et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. , 2004, Gastroenterology.
[48] Lloyd H. Michael,et al. The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.
[49] A. Chlumská,et al. [Alcoholic hepatitis]. , 1987, Casopis lekaru ceskych.